Literature DB >> 10395626

The effect of synbiotics on colon carcinogenesis in rats.

D D Gallaher1, J Khil.   

Abstract

Evidence indicates that consumption of probiotic microorganisms such as bifidobacteria reduces the risk of colon cancer in animal models. Feeding certain fructans such as oligofructose and inulin, which are thought to selectively increase the growth of intestinal bifidobacteria (i.e., a prebiotic effect), also has been shown to reduce colon cancer risk. The objective of our study was twofold, i. e., to determine whether the combination of bifidobacteria and oligofructose would have an additive effect (i.e., synbiotic) in reducing colon cancer risk in rats, and to determine whether other oligosaccharides would also be effective as part of a synbiotic combination. The development of colonic preneoplastic lesions (aberrant crypts) was used as an index of colon cancer risk. In one series of experiments, rats were given the carcinogen 1, 2-dimethylhydrazine (DMH) and administered one of the following treatments: skim milk (control), bifidobacteria (bifido), oligofructose (OF) or bifido + OF. Neither bifido nor OF alone significantly reduced aberrant crypt number. Bifido + OF reduced aberrant crypt number in five of six experiments, although the reduction was significant in only one. However, a paired comparison of the six experiments indicated a significant overall reduction in aberrant crypts by bifido + OF (P = 0.039). Soybean oligosaccharide (SBO) and wheat bran oligosaccharide (WBO) were also fed in combination with bifidobacteria. In two other experiments, SBO did not alter the number of aberrant crypts compared with the control, whereas WBO reduced aberrant crypt number in one experiment but not in another. Of OF, SBO and WBO, only SBO reduced the colonic mucosa proliferation compared with the control. These results suggest that the combination of bifidobacteria and oligofructose reduces colon cancer risk in carcinogen-treated rats, but the effect of other oligosaccharides is uncertain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395626     DOI: 10.1093/jn/129.7.1483S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  11 in total

1.  Influence of whole peptidoglycan of bifidobacterium on cytotoxic effectors produced by mouse peritoneal macrophages.

Authors:  L S Wang; H M Zhu; D Y Zhou; Y L Wang; W D Zhang
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

Review 2.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

3.  The effects of probiotic, prebiotic and synbiotic diets containing Bacillus coagulans and inulin on rat intestinal microbiota.

Authors:  Kh Abhari; S S Shekarforoush; J Sajedianfard; S Hosseinzadeh; S Nazifi
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

4.  Modulation of rat cecal microbiota by administration of raffinose and encapsulated Bifidobacterium breve.

Authors:  Achmad Dinoto; Akarat Suksomcheep; Satoshi Ishizuka; Hanae Kimura; Satoshi Hanada; Yoichi Kamagata; Kozo Asano; Fusao Tomita; Atsushi Yokota
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

5.  Lack of inhibitory effects of lactic acid bacteria on 1,2-dimethylhydrazine-induced colon tumors in rats.

Authors:  Wei Li; Chong-Bi Li
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

6.  Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and Reduces Cancer via TLR2 Signaling in a Rat Model of Colon Cancer.

Authors:  Eugene Dogkotenge Kuugbee; Xueqi Shang; Yaser Gamallat; Djibril Bamba; Annoor Awadasseid; Mohammed Ahmed Suliman; Shizhu Zang; Yufang Ma; Gift Chiwala; Yi Xin; Dong Shang
Journal:  Dig Dis Sci       Date:  2016-07-06       Impact factor: 3.199

7.  Comparative analysis of protein-protein interactions in cancer-associated genes.

Authors:  Purnima Guda; Sridar V Chittur; Chittibabu Guda
Journal:  Genomics Proteomics Bioinformatics       Date:  2009-06       Impact factor: 7.691

8.  Novel Combination of Prebiotics Galacto-Oligosaccharides and Inulin-Inhibited Aberrant Crypt Foci Formation and Biomarkers of Colon Cancer in Wistar Rats.

Authors:  Tahir Rasool Qamar; Fatima Syed; Muhammad Nasir; Habib Rehman; Muhammad Nauman Zahid; Rui Hai Liu; Sanaullah Iqbal
Journal:  Nutrients       Date:  2016-08-01       Impact factor: 5.717

9.  FBLN4 as candidate gene associated with long-term and short-term survival with primary glioblastoma.

Authors:  Fubin Li; Yiping Li; Kewei Zhang; Ye Li; Ping He; Yujia Liu; Hongyan Yuan; Honghua Lu; Jinxiang Liu; Songtian Che; Zhenju Li; Li Bie
Journal:  Onco Targets Ther       Date:  2017-01-16       Impact factor: 4.147

10.  Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence.

Authors:  Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2008-05-20       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.